Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
about
Hemolytic uremic syndrome: new developments in pathogenesis and treatmentShiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.Hemolytic uremic syndromeHemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature.Shiga toxin type-2 (Stx2) induces glutamate release via phosphoinositide 3-kinase (PI3K) pathway in murine neuronsEpidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome.Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?Anaerobic conditions promote expression of Sfp fimbriae and adherence of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM to human intestinal epithelial cells.Outbreak of haemolytic uraemic syndrome in Norway caused by stx2-positive Escherichia coli O103:H25 traced to cured mutton sausagesComparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany.Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome.Distribution of the urease gene cluster among and urease activities of enterohemorrhagic Escherichia coli O157 isolates from humansChildhood hemolytic uremic syndrome, United Kingdom and Ireland.Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM.Haemolytic uraemic syndrome: an overview.The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activitySporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison.Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome.Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody.Shiga toxin-producing Escherichia coli serogroups in food and patients, GermanySorbitol-fermenting enterohaemorrhagic Escherichia coli O157:H- causes another outbreak of haemolytic uraemic syndrome in children.Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy.The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.Renal and neurological involvement in typical Shiga toxin-associated HUS.Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.Secondary, profound, sensorineural hearing loss after recovery from haemolytic uraemic syndrome due to enterohaemorrhagic Escherichia coli, and subsequent cochlear implantation, in two Japanese children.Filter membrane-based automated therapeutic plasma exchange: a report of two cases from Nigeria.Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infection.Multistate outbreak of Escherichia coli O145 infections associated with romaine lettuce consumption, 2010.Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.Evolution of enterohemorrhagic escherichia coli O26 based on single-nucleotide polymorphisms.Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome.
P2860
Q24613517-94899240-DACE-4D5F-A002-6F22E2ED2731Q24658046-DBBDDDC3-BCA0-4799-B3A9-7171EFEC782DQ26799054-5604D353-8767-4C98-9D95-93DF4B974B5EQ30249618-1198766A-CA90-4F5A-B315-A1D4349AE89FQ30657658-D10B334C-513A-4215-A087-DA32622E2738Q31010561-3E4A6C9B-A5F5-408A-B768-8ABD55F98156Q31118140-45B14B7D-ABE0-46A7-8A26-778D8760A270Q33302118-A51AA9D4-B48B-48B0-9E38-C1B25E681238Q33310576-0385CB5A-D61B-44A6-9F87-AA5C3773204EQ33326889-787D9869-9405-4F1B-9310-C069EEBD9813Q33346383-1B49AB8B-F11C-465B-98F5-BE33CA195A39Q33359875-8EB514F0-EF34-45BD-B069-A62BEF7C7EFDQ33363266-63686EFB-F812-48D8-9BBF-7694C94C7CA9Q33364401-DBAA08A8-BDC8-4D2C-9F6F-170831EB5307Q33364864-C82D8225-B6A0-4C8D-A44E-21AA7B2EF148Q33365828-0F4A0D96-3428-4B38-8005-C07F6F94F660Q33370432-90D278D0-39BF-4CD8-85C4-CB1F4ABA6136Q33371444-3150082F-E484-41B9-AAEF-FAA821F5597FQ33373301-04D32472-A417-4520-9780-E9B5A7D64CBEQ33375505-CFD710A6-6BF7-4BF6-AE0F-D416EC253D34Q33376279-ED565D0C-9B4B-4861-A7C4-5D23280B9709Q33379319-3311DE4B-5D7C-40F3-A587-510C552EF015Q33379683-FD530BC8-083D-4E6A-98D4-B0F8301B82F1Q33380705-95886E64-DD54-4B8C-BBE7-77A7B8402933Q33381863-F2B157CD-BD3E-442F-A440-40D492475F5AQ33382082-54699255-D67E-4988-A357-DEF113D8F36AQ33396577-EA9F026A-1ACB-4B4F-88EC-9B7CA4BB6AD4Q33397450-34D342D0-CB26-4B34-8EE9-450F138ACFB9Q33400961-9A1BF6A9-25E7-4511-8F42-81228A5E38A0Q33401628-FE073BF0-818B-4A2C-B374-49BC9B44617CQ33403361-6F7A28DA-70A0-45E8-AC74-DE08ED48E144Q33404847-B6E8BD38-BCAC-44BB-9018-4D6C027D6A5AQ33405827-DAD4D744-5868-4F2A-8871-5DE5E40F084BQ33405856-CBFA67BE-12F6-432A-96ED-4DF6F93658CFQ33405969-1B6379DE-B7F0-44F8-BF8B-1372A8C17310Q33406669-55C9E25C-D5ED-4290-BEFC-E0957A98A71BQ33408119-AB7FC7FB-755B-44FF-86FB-A76EE9DE5B38Q33409684-4AE71393-22F1-4569-BBE8-5CB478247F81Q33410817-6A381192-D789-4DE9-91F1-730F3C42214CQ33414177-EA75F7E6-0FAD-4782-BF58-F41A490C9B75
P2860
Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical course and the role o ...... Austria: a prospective study.
@ast
Clinical course and the role o ...... Austria: a prospective study.
@en
type
label
Clinical course and the role o ...... Austria: a prospective study.
@ast
Clinical course and the role o ...... Austria: a prospective study.
@en
prefLabel
Clinical course and the role o ...... Austria: a prospective study.
@ast
Clinical course and the role o ...... Austria: a prospective study.
@en
P2093
P356
P1476
Clinical course and the role o ...... Austria: a prospective study.
@en
P2093
Angela Gerber
Hege M Verweyen
Lothar B Zimmerhackl
P304
P356
10.1086/341940
P407
P577
2002-08-02T00:00:00Z